The global Contract Bio-manufacturing Organization (CMO) market size was valued at US$ million in 2023. With growing demand in downstream market, the Contract Bio-manufacturing Organization (CMO) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Contract Bio-manufacturing Organization (CMO) market. Contract Bio-manufacturing Organization (CMO) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Contract Bio-manufacturing Organization (CMO). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Contract Bio-manufacturing Organization (CMO) market.
药品合同生产组织(颁惭翱)是一种新兴外包服务模式,主要接受制药公司的委托,为其提供生产工艺的开发、改进服务以及临床试验和商业化销售药物所用中间体、原料药、制剂的生产供应服务。
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Contract Bio-manufacturing Organization (CMO) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Contract Bio-manufacturing Organization (CMO) market. It may include historical data, market segmentation by Type (e.g., Big Bio/Pharma Type, Small/Med Bio/Pharma Type), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Contract Bio-manufacturing Organization (CMO) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Contract Bio-manufacturing Organization (CMO) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Contract Bio-manufacturing Organization (CMO) industry. This include advancements in Contract Bio-manufacturing Organization (CMO) technology, Contract Bio-manufacturing Organization (CMO) new entrants, Contract Bio-manufacturing Organization (CMO) new investment, and other innovations that are shaping the future of Contract Bio-manufacturing Organization (CMO).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Contract Bio-manufacturing Organization (CMO) market. It includes factors influencing customer ' purchasing decisions, preferences for Contract Bio-manufacturing Organization (CMO) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Contract Bio-manufacturing Organization (CMO) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Contract Bio-manufacturing Organization (CMO) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Contract Bio-manufacturing Organization (CMO) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Contract Bio-manufacturing Organization (CMO) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Contract Bio-manufacturing Organization (CMO) market.
Market Segmentation:
Contract Bio-manufacturing Organization (CMO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Big Bio/Pharma Type
Small/Med Bio/Pharma Type
Virtual/Emerging Type
Segmentation by application
Pharmaceutical Industry
Biotechnology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abzena
Althea
Asymchem Laboratories Inc.
Baxter Biopharma Solutions
Biomeva
Boehringer Ingelheim
Celltrion
AGC Biologics
Cytovance Biologics
Fujifilm Diosynth Technologies
KBI Biopharma
Lonza Group
MicroProtein Technologies
Patheon
Porton Pharma Solutions
Probiogen
Rader
Rentschler Biotechnologie
Samsung
Sandoz
STA Pharmaceutical Co. Ltd
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Contract Bio-manufacturing Organization (CMO) Market Size 2019-2030
2.1.2 Contract Bio-manufacturing Organization (CMO) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Contract Bio-manufacturing Organization (CMO) Segment by Type
2.2.1 Big Bio/Pharma Type
2.2.2 Small/Med Bio/Pharma Type
2.2.3 Virtual/Emerging Type
2.3 Contract Bio-manufacturing Organization (CMO) Market Size by Type
2.3.1 Contract Bio-manufacturing Organization (CMO) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Contract Bio-manufacturing Organization (CMO) Market Size Market Share by Type (2019-2024)
2.4 Contract Bio-manufacturing Organization (CMO) Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Biotechnology
2.4.3 Others
2.5 Contract Bio-manufacturing Organization (CMO) Market Size by Application
2.5.1 Contract Bio-manufacturing Organization (CMO) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Contract Bio-manufacturing Organization (CMO) Market Size Market Share by Application (2019-2024)
3 Contract Bio-manufacturing Organization (CMO) Market Size by Player
3.1 Contract Bio-manufacturing Organization (CMO) Market Size Market Share by Players
3.1.1 Global Contract Bio-manufacturing Organization (CMO) Revenue by Players (2019-2024)
3.1.2 Global Contract Bio-manufacturing Organization (CMO) Revenue Market Share by Players (2019-2024)
3.2 Global Contract Bio-manufacturing Organization (CMO) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Contract Bio-manufacturing Organization (CMO) by Regions
4.1 Contract Bio-manufacturing Organization (CMO) Market Size by Regions (2019-2024)
4.2 Americas Contract Bio-manufacturing Organization (CMO) Market Size Growth (2019-2024)
4.3 APAC Contract Bio-manufacturing Organization (CMO) Market Size Growth (2019-2024)
4.4 Europe Contract Bio-manufacturing Organization (CMO) Market Size Growth (2019-2024)
4.5 Middle East & Africa Contract Bio-manufacturing Organization (CMO) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Contract Bio-manufacturing Organization (CMO) Market Size by Country (2019-2024)
5.2 Americas Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
5.3 Americas Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contract Bio-manufacturing Organization (CMO) Market Size by Region (2019-2024)
6.2 APAC Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
6.3 APAC Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Contract Bio-manufacturing Organization (CMO) by Country (2019-2024)
7.2 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
7.3 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Contract Bio-manufacturing Organization (CMO) by Region (2019-2024)
8.2 Middle East & Africa Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
8.3 Middle East & Africa Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Contract Bio-manufacturing Organization (CMO) Market Forecast
10.1 Global Contract Bio-manufacturing Organization (CMO) Forecast by Regions (2025-2030)
10.1.1 Global Contract Bio-manufacturing Organization (CMO) Forecast by Regions (2025-2030)
10.1.2 Americas Contract Bio-manufacturing Organization (CMO) Forecast
10.1.3 APAC Contract Bio-manufacturing Organization (CMO) Forecast
10.1.4 Europe Contract Bio-manufacturing Organization (CMO) Forecast
10.1.5 Middle East & Africa Contract Bio-manufacturing Organization (CMO) Forecast
10.2 Americas Contract Bio-manufacturing Organization (CMO) Forecast by Country (2025-2030)
10.2.1 United States Contract Bio-manufacturing Organization (CMO) Market Forecast
10.2.2 Canada Contract Bio-manufacturing Organization (CMO) Market Forecast
10.2.3 Mexico Contract Bio-manufacturing Organization (CMO) Market Forecast
10.2.4 Brazil Contract Bio-manufacturing Organization (CMO) Market Forecast
10.3 APAC Contract Bio-manufacturing Organization (CMO) Forecast by Region (2025-2030)
10.3.1 China Contract Bio-manufacturing Organization (CMO) Market Forecast
10.3.2 Japan Contract Bio-manufacturing Organization (CMO) Market Forecast
10.3.3 Korea Contract Bio-manufacturing Organization (CMO) Market Forecast
10.3.4 Southeast Asia Contract Bio-manufacturing Organization (CMO) Market Forecast
10.3.5 India Contract Bio-manufacturing Organization (CMO) Market Forecast
10.3.6 Australia Contract Bio-manufacturing Organization (CMO) Market Forecast
10.4 Europe Contract Bio-manufacturing Organization (CMO) Forecast by Country (2025-2030)
10.4.1 Germany Contract Bio-manufacturing Organization (CMO) Market Forecast
10.4.2 France Contract Bio-manufacturing Organization (CMO) Market Forecast
10.4.3 UK Contract Bio-manufacturing Organization (CMO) Market Forecast
10.4.4 Italy Contract Bio-manufacturing Organization (CMO) Market Forecast
10.4.5 Russia Contract Bio-manufacturing Organization (CMO) Market Forecast
10.5 Middle East & Africa Contract Bio-manufacturing Organization (CMO) Forecast by Region (2025-2030)
10.5.1 Egypt Contract Bio-manufacturing Organization (CMO) Market Forecast
10.5.2 South Africa Contract Bio-manufacturing Organization (CMO) Market Forecast
10.5.3 Israel Contract Bio-manufacturing Organization (CMO) Market Forecast
10.5.4 Turkey Contract Bio-manufacturing Organization (CMO) Market Forecast
10.5.5 GCC Countries Contract Bio-manufacturing Organization (CMO) Market Forecast
10.6 Global Contract Bio-manufacturing Organization (CMO) Forecast by Type (2025-2030)
10.7 Global Contract Bio-manufacturing Organization (CMO) Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Abzena
11.1.1 Abzena Company Information
11.1.2 Abzena Contract Bio-manufacturing Organization (CMO) Product Offered
11.1.3 Abzena Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abzena Main Business Overview
11.1.5 Abzena Latest Developments
11.2 Althea
11.2.1 Althea Company Information
11.2.2 Althea Contract Bio-manufacturing Organization (CMO) Product Offered
11.2.3 Althea Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Althea Main Business Overview
11.2.5 Althea Latest Developments
11.3 Asymchem Laboratories Inc.
11.3.1 Asymchem Laboratories Inc. Company Information
11.3.2 Asymchem Laboratories Inc. Contract Bio-manufacturing Organization (CMO) Product Offered
11.3.3 Asymchem Laboratories Inc. Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Asymchem Laboratories Inc. Main Business Overview
11.3.5 Asymchem Laboratories Inc. Latest Developments
11.4 Baxter Biopharma Solutions
11.4.1 Baxter Biopharma Solutions Company Information
11.4.2 Baxter Biopharma Solutions Contract Bio-manufacturing Organization (CMO) Product Offered
11.4.3 Baxter Biopharma Solutions Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Baxter Biopharma Solutions Main Business Overview
11.4.5 Baxter Biopharma Solutions Latest Developments
11.5 Biomeva
11.5.1 Biomeva Company Information
11.5.2 Biomeva Contract Bio-manufacturing Organization (CMO) Product Offered
11.5.3 Biomeva Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Biomeva Main Business Overview
11.5.5 Biomeva Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Contract Bio-manufacturing Organization (CMO) Product Offered
11.6.3 Boehringer Ingelheim Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Celltrion
11.7.1 Celltrion Company Information
11.7.2 Celltrion Contract Bio-manufacturing Organization (CMO) Product Offered
11.7.3 Celltrion Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Celltrion Main Business Overview
11.7.5 Celltrion Latest Developments
11.8 AGC Biologics
11.8.1 AGC Biologics Company Information
11.8.2 AGC Biologics Contract Bio-manufacturing Organization (CMO) Product Offered
11.8.3 AGC Biologics Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AGC Biologics Main Business Overview
11.8.5 AGC Biologics Latest Developments
11.9 Cytovance Biologics
11.9.1 Cytovance Biologics Company Information
11.9.2 Cytovance Biologics Contract Bio-manufacturing Organization (CMO) Product Offered
11.9.3 Cytovance Biologics Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cytovance Biologics Main Business Overview
11.9.5 Cytovance Biologics Latest Developments
11.10 Fujifilm Diosynth Technologies
11.10.1 Fujifilm Diosynth Technologies Company Information
11.10.2 Fujifilm Diosynth Technologies Contract Bio-manufacturing Organization (CMO) Product Offered
11.10.3 Fujifilm Diosynth Technologies Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fujifilm Diosynth Technologies Main Business Overview
11.10.5 Fujifilm Diosynth Technologies Latest Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Information
11.11.2 KBI Biopharma Contract Bio-manufacturing Organization (CMO) Product Offered
11.11.3 KBI Biopharma Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 KBI Biopharma Main Business Overview
11.11.5 KBI Biopharma Latest Developments
11.12 Lonza Group
11.12.1 Lonza Group Company Information
11.12.2 Lonza Group Contract Bio-manufacturing Organization (CMO) Product Offered
11.12.3 Lonza Group Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Lonza Group Main Business Overview
11.12.5 Lonza Group Latest Developments
11.13 MicroProtein Technologies
11.13.1 MicroProtein Technologies Company Information
11.13.2 MicroProtein Technologies Contract Bio-manufacturing Organization (CMO) Product Offered
11.13.3 MicroProtein Technologies Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 MicroProtein Technologies Main Business Overview
11.13.5 MicroProtein Technologies Latest Developments
11.14 Patheon
11.14.1 Patheon Company Information
11.14.2 Patheon Contract Bio-manufacturing Organization (CMO) Product Offered
11.14.3 Patheon Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Patheon Main Business Overview
11.14.5 Patheon Latest Developments
11.15 Porton Pharma Solutions
11.15.1 Porton Pharma Solutions Company Information
11.15.2 Porton Pharma Solutions Contract Bio-manufacturing Organization (CMO) Product Offered
11.15.3 Porton Pharma Solutions Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Porton Pharma Solutions Main Business Overview
11.15.5 Porton Pharma Solutions Latest Developments
11.16 Probiogen
11.16.1 Probiogen Company Information
11.16.2 Probiogen Contract Bio-manufacturing Organization (CMO) Product Offered
11.16.3 Probiogen Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Probiogen Main Business Overview
11.16.5 Probiogen Latest Developments
11.17 Rader
11.17.1 Rader Company Information
11.17.2 Rader Contract Bio-manufacturing Organization (CMO) Product Offered
11.17.3 Rader Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Rader Main Business Overview
11.17.5 Rader Latest Developments
11.18 Rentschler Biotechnologie
11.18.1 Rentschler Biotechnologie Company Information
11.18.2 Rentschler Biotechnologie Contract Bio-manufacturing Organization (CMO) Product Offered
11.18.3 Rentschler Biotechnologie Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Rentschler Biotechnologie Main Business Overview
11.18.5 Rentschler Biotechnologie Latest Developments
11.19 Samsung
11.19.1 Samsung Company Information
11.19.2 Samsung Contract Bio-manufacturing Organization (CMO) Product Offered
11.19.3 Samsung Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Samsung Main Business Overview
11.19.5 Samsung Latest Developments
11.20 Sandoz
11.20.1 Sandoz Company Information
11.20.2 Sandoz Contract Bio-manufacturing Organization (CMO) Product Offered
11.20.3 Sandoz Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Sandoz Main Business Overview
11.20.5 Sandoz Latest Developments
11.21 STA Pharmaceutical Co. Ltd
11.21.1 STA Pharmaceutical Co. Ltd Company Information
11.21.2 STA Pharmaceutical Co. Ltd Contract Bio-manufacturing Organization (CMO) Product Offered
11.21.3 STA Pharmaceutical Co. Ltd Contract Bio-manufacturing Organization (CMO) Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 STA Pharmaceutical Co. Ltd Main Business Overview
11.21.5 STA Pharmaceutical Co. Ltd Latest Developments
12 Research Findings and Conclusion
?
?
*If Applicable.
